Asia's Ascent — Global Trends in Biomedical R&D Expenditures

Globalization and changing trends of biomedical research output

“…This stagnation in federal support for research raises many concerns, including whether the US will ultimately lose its global lead in biomedical research output and innovation as measured by scientific research articles, patents, and science and technology workforce (3). This concern is fueled by the relative decline in public sector and private industry research and development (R&D) expenditures in the US (compound -1.9% annual growth rate for 2007 to 2012, adjusted for inflation), as compared with an increase of 32.8% for China and 10%-11% for Singapore and South Korea (4).…”

How to transform the practice of engineering to meet global health needs

“…First, rapidly expanding health care markets in emerging economies are drawing the interest of multinational corporations (3). Inflation-adjusted biomedical research and development expenditures increased in India and China by 6.7% and 32.8% per year, respectively, from 2007 to 2012; in contrast, expenditures in the United States, Canada, and Europe decreased over the same period (24). Likewise, an increase in accountable care organizations may drive investment in resource-saving technologies in the United States.…”

Emphasizing unique strengths and eliminating redundancy for research in low‐income and middle‐income countries: Lessons from a South American country

“…1 Data from the World Bank demonstrate that LMIC spend approximately 1.24% of their gross domestic product on research and development efforts. In contrast, high-income countries spend, on average, 2.32% of their gross domestic product on such efforts.…”